Prevalence of coronary artery disease and coronary microvascular dysfunction in heart failure with preserved ejection fraction

Back

ESC Premium Access

Prevalence of coronary artery disease and coronary microvascular dysfunction in heart failure with preserved ejection fraction

Session: HFpEF: What's new in 2019

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor C. Rush (Clydebank, GB)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Christopher Rush

Golden Jubilee National Hospital, Clydebank (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

5 more presentations in this session

Change in geriatric nutritional risk index predicts one-year mortality in patients with heart failure with preserved ejection fraction

Speaker: Doctor A. Sunaga (Suita, JP)

Elevated plasma xanthine oxidoreductase activity predicts cardiovascular events in patients with heart failure with preserved ejection fraction

Speaker: Doctor K. Watanabe (Yamagata, JP)

The effect of parity on exercise physiology in women with heart failure with preserved ejection fraction

Speaker: Doctor A. Beale (Melbourne, AU)

Left atrial phasic function in heart failure with preserved ejection fraction: cardiac magnetic resonance myocardial feature tracking, invasive hemodynamics and outcome

Speaker: Doctor R. Schoenbauer (Vienna, AT)

Imaging criteria for the diagnosis of heart failure with midrange and preserved LVEF in the real life

Speaker: Doctor E. Paven (Rennes, FR)

Access the full session

HFpEF: What's new in 2019

Speakers: Doctor C. Rush, Doctor A. Sunaga, Doctor K. Watanabe, Doctor A. Beale, Doctor R. Schoenbauer...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources